Quarterly Result28 Apr 2026, 06:51 pm
Sanofi India Board Approves Q1 FY27 Results; New Chairman Appointed
AI Summary
Sanofi India's Board of Directors approved the unaudited financial results for the quarter ended March 31, 2026. Additionally, the tenure of Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat concluded on April 29, 2026. Mr. Rahul Bhatnagar was appointed as the new Chairman of the Board, effective April 30, 2026. The company also re-constituted its Audit, Nomination and Remuneration, Stakeholders Relationship, Risk Management, and Corporate Social Responsibility Committees, effective April 30, 2026.
Key Highlights
- Board approved unaudited financial results for the quarter ended March 31, 2026.
- Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat completed their tenure.
- Mr. Rahul Bhatnagar appointed as the new Chairman of the Board from April 30, 2026.
- Key board committees including Audit and Nomination & Remuneration were re-constituted.